Literature DB >> 15150830

Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry.

Sang Kyu Lee1, Jaeick Lee, Eung-Seok Lee, Yurngdong Jahng, Dong-Hyun Kim, Tae Cheon Jeong.   

Abstract

Following incubation of rutaecarpine, a new cyclooxygenase-2 inhibitor, with rat liver microsomes, the structures of the metabolites were characterized by liquid chromatography with tandem mass spectrometry. Nine metabolites corresponding to mono- or dihydroxylated rutaecarpine were formed. Characteristic product ions for the identification of rutaecarpine metabolites were observed at m/z 136, 158 and 286. The loss of water led to the fragment ion at m/z 286, indicating the hydroxylation of the aliphatic ring. The fragment ion at m/z 136 indicated the hydroxylated form of the phenyl group of the quinazolinone moiety, while that at m/z 158 indicated the hydroxylated form of the aromatic ring of the indole moiety. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150830     DOI: 10.1002/rcm.1448

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  3 in total

1.  Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.

Authors:  Sudeep R Bista; Sang Kyu Lee; Dinesh Thapa; Mi Jeong Kang; Young Min Seo; Ju Hyun Kim; Dong Hyeon Kim; Yurngdong Jahng; Jung Ae Kim; Tae Cheon Jeong
Journal:  Toxicol Res       Date:  2008-09-01

Review 2.  Progress in the studies on rutaecarpine.

Authors:  Seung Ho Lee; Jong-Keun Son; Byeong Seon Jeong; Tae-Cheon Jeong; Hyeon Wook Chang; Eung-Seok Lee; Yurngdong Jahng
Journal:  Molecules       Date:  2008-02-06       Impact factor: 4.411

Review 3.  Processing and Polyherbal Formulation of Tetradium ruticarpum (A. Juss.) Hartley: Phytochemistry, Pharmacokinetics, and Toxicity.

Authors:  Qi-Yuan Shan; Xia-Nan Sang; Hui Hui; Qi-Yang Shou; Hui-Ying Fu; Min Hao; Kao-Hua Liu; Qiao-Yan Zhang; Gang Cao; Lu-Ping Qin
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.